Fibromyalgia
Conditions
Interventions
This is a two-arm, single-blind, randomized controlled clinical trial. Experimental group: 12 women with fibromyalgia received vetotherapy treatment for 20 minutes on the bladder meridian (dorsal Shu)
Sponsors
Adriana Teresa Silva
Universidade Federal de Alfenas
Eligibility
Sex/Gender
Female
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 30 and 65 years old; female and presenting the clinical diagnosis with fibromyalgia syndrome;; for more than three consecutive months; which was based on the diagnostic criteria of the American College of Rheumatology (2010); accept to participate and sign the Informed Consent Term (TCLE)
Exclusion criteria
Exclusion criteria: Patients who had dermatological disorders at the application site; presence of deep venous thrombosis; presence of central and peripheral nervous system injury; orthopedic surgeries performed at the application site and did not accept signing the TLCE were excluded from the present study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1 that will be analyzed using the Numerical Pain Scale. It is expected to find a significant difference in the reduction of less than 2 scores in pain perception in the experimental group;Outcome found 1 analyzed using the Numeric Pain Scale. In the study sample, we did not find a significant difference in pain reduction in the experimental group;Expected outcome 2 which will be analyzed using the 2010 American College of Rheumatology scale for the diagnosis of fibromyalgia. It is expected to find significant statistical differences in the total score and subitems of the scale with a reduction in values when comparing groups and between times in the experimental group;Outcome found 2 analyzed using the 2010 American College of Rheumatology scale for the diagnosis of fibromyalgia. In the subscale named generalized pain index, we found a statistically significant difference in the comparison between pre- and post-intervention times | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 3 which will be analyzed using the Fibromyalgia Impact Questionnaire. It is expected to find a significant statistical difference in the decrease in total scores and scale subitems when comparing groups and between the initial and final times in the experimental group;Outcome found 3 analyzed by the Fibromyalgia Impact Questionnaire. We found a statistically significant difference within the group in the total score of the scale and in the sub-items for the variables It interfered with your ability to do your job, Did you feel pain and Rigidity, there was a reduction in the values obtained;Expected outcome 4 which will be analyzed using the Functional movement screening scale. It is expected to find a significant statistical difference in the increase in total scale scores when comparing groups and between the initial and final times in the experimental group;Outcome found 4 analyzed by the Functional movement screening scale. We found no statistically significant difference either within the group or between the groups;Expected outcome 5 which will be analyzed by the flexibility test (Finger on the floor test). It is expected to find a statistically significant difference in the reduction in the values found in the test in the comparison between groups and between times for the experimental group;Outcome found 5 analyzed by the flexibility test (Finger on the floor test). We found no statistically significant difference either within the group or between the groups | — |
Countries
Brazil
Contacts
Public ContactAdriana Santos
Universidade Federal de Alfenas
Outcome results
None listed